Galena Biopharma (GALE) Posts Surprise Q4 Profit of 4c/Share

Galena Biopharma (NASDAQ: GALE) reported Q4 EPS of $0.04, $0.19 better than the analyst estimate of ($0.15).

For earnings history and earnings-related data on Galena Biopharma (GALE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Inhibrx, Inc. (INBX) Misses Q2 EPS by 54c
• Innovaro (INV) Misses Q2 EPS by 9c